Blazejewski MEDI-TECH GmbH is a leading manufacturer of medical endoscopes SHS is acquiring a 24.9-percent stake in the company Blazejewski intends to advance sales and internationalization with the aid of SHS SHS Gesellschaft fuer Beteiligungsmanagement mbH, the Tuebingen-based investor in medical technology and life sciences, is investing in Baden-Wuerttemberg-based endoscope specialist Blazejewski MEDI-TECH GmbH. The […]

Unquote reported on SHS backing mental health therapy provider Selfapy in their recent financing round. Selfapy raised the money to conduct further clinical studies and to continue to expand nationally and internationally. Selfapy is SHS first investment in the digital health sector and is expected to have high growth potential due to the new German […]

Selfapy is Germany’s leading provider of online therapy for mental stress and is already cooperating with 16 health insurance funds SHS is expecting strong impulses for digital health companies from Germany’s new Digital Healthcare Act (DVG) Fifth investment of SHS’ fifth fund: Medical technology and life science investor SHS Gesellschaft für Beteiligungsmanagement of Tübingen, Germany, […]

The medtech zwo magazine reported on the participation of SHS Tübingen in the endoscopy manufacturer Blazejewski MEDI-Tech GmbH from Sexau. The company develops and produces endoscopes and endoscopy cameras. Within the scope of a partnership with the lighting specialist Photonic, the visual characteristics of the endoscopes are being improved, which also offers enormous potential for […]

In January, the Handelsblatt reported on the current financing round of Selfapy, a psychotherapy start-up that wants to make better and faster psychotherapy treatment possible with its app. Selfapy offers online courses for the treatment of burnout, depression, anxiety and eating disorders. Selfapy hopes that the new German digital care law (DVG) will make their […]

Single Use Support has been announced winner in the export category of the Young Entrepreneurs Award presented by Austrian business magazine “Gewinn”. Furthermore, the start-up was ranked fifth of 100 in the overall ranking.

“Swimming for All Children” is organized on a voluntary basis and was established in April 2015 in cooperation with Runder Tisch Kinderarmut (Round Table on Child Poverty) and Bündnis für Familie (Alliance for the Family) in Tübingen. A survey conducted by the German Life Saving Association found that 59% of children are not confident swimmers […]

In an interview with Hubertus Leonhardt, managing director and partner of SHS, and Manfred Ulmer-Weber, investment manager and partner at SHS, VC Magazin reports on the development of the company and its current fifth fund (SHS V). SHS Tübingen has developed into one of the largest industry specialists in the medical technology and life science […]

As a solution provider for the life science industry, Single Use Support (SUS) increases patient safety and minimizes the risk of contamination SUS customers include well-known companies from Europe, Asia and America SUS platform technology can become the industry standard for fluid logistics processes in the life science, biotech, pharmaceutical and medical device industries The […]

The medtech zwo magazine reports on developments in robot-assisted surgery. The SHS portfolio company AOT has developed an innovative procedure for bone surgery with its laser osteotomy robot Carlo. The robot is able to perform complicated operations on the bone independently under the supervision of a surgeon using a new type of laser cutting process. […]

medtech zwo magazine spoke in an interview with Hubertus Leonhardt, Managing Director and Partner of SHS, about the current situation in the medical technology sector. The SHS Medical Technology Index, which was developed in cooperation between Christan Koziol, Professor and Chair of Finance at the University of Tübingen, and SHS, quantifies developments and industry trends. […]

Early non-invasive detection of kidney rejection after transplantation was the central aim of a collaboration between Prof. Dr. Bernhard Banas, Chairman of Nephrology at the University Hospital Regensburg (UKR) and the medical diagnostics company, numares. The results of their joint clinical trial “UMBRELLA” were just published in EBioMedicine and will be presented right now at the American Society of Nephrology’s […]